Sunshine Biopharma, Inc. (SBFM) Ownership

NASDAQ: SBFMTop holders, insider trades and short interest.

SBFM ownership summary

as of October 17, 2026
Institutions
7.8%
of shares outstanding
Insiders
6.43%
of shares outstanding
Shares outstanding
14.8M
Float
2.9M
shares available to trade
Short interest
3.10%
131K shares short
Days to cover
0.85
short interest up 461.6% vs prior month
  • Institutions 7.79%
  • Insiders 6.43%
  • Other investors 85.78%

SBFM top institutional holders

17 largest
Sunshine Biopharma, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Jane Street Group LLC3.05%15K$3,324+14,974 (0.0%)June 30, 2026
2Morgan Stanley - Brokerage Accounts0.08%385$85−1,078 (−73.7%)June 30, 2026
3SBI Securities Co Ltd0.03%162$36−21 (−11.5%)June 30, 2026
4NATIONAL BANK OF CANADA /FI/<0.01%5$1+4 (+400.0%)June 30, 2026
5Advisor Group Holdings, Inc.<0.01%2$0+2 (0.0%)June 30, 2026
6TD Waterhouse Canada Inc<0.01%1$0+1 (0.0%)June 30, 2026
7Caitong International Asset Management Co., Limited.<0.01%1$0+1 (0.0%)June 30, 2026
8Strive Financial Group ,LLC<0.01%1$0+1 (0.0%)June 30, 2026
9Commonwealth Equity Services, LLC0.00%——−1,344 (−100.0%)June 30, 2026
10Sageview Advisory Group LLC0.00%———June 30, 2026
11Citadel Advisors Llc0.00%——−4,625 (−100.0%)June 30, 2026
12UBS Group AG0.00%——−110 (−100.0%)June 30, 2026
13Virtu Financial LLC0.00%——−23,388 (−100.0%)March 31, 2026
14XTX Topco Ltd0.00%——−2,146 (−100.0%)June 30, 2026
15CoreCap Advisors, LLC0.00%———June 30, 2026
16TWO SIGMA SECURITIES, LLC0.00%——−2,348 (−100.0%)June 30, 2026
17Bank of America Corp0.00%——−5 (−100.0%)March 31, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 17, 6 holders added 15K shares and 9 cut 35K.

SBFM top mutual fund and ETF holders

3 largest
Sunshine Biopharma, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Stewardship Partners US Multifactor0.20%4,187$930+4,187 (0.0%)June 30, 2026
2Stewardship Partners Global Multifactor0.08%1,690$375+1,690 (0.0%)June 30, 2026
3Stewardship Partners Glb Multi Tax-Eff0.03%678$151+678 (0.0%)June 30, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

SBFM insider transactions

latest 1
Sunshine Biopharma, Inc. insider transactions
DateNameTransactionPriceSharesValue
2024-03-04Steve N SlilatyBuy$10.001,000$10,000

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

SBFM shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns SBFM

Institutional investors own 7.8% of Sunshine Biopharma's shares and insiders 6.43%. The largest holder is Jane Street Group LLC with 3.05% of the shares (15K), as of June 30, 2026. Among the top 17 institutions, 6 added shares and 9 reduced their stake in the latest filings. Short interest is 3.10% of the float, or 0.85 days of average trading volume. The share count rose 490,500.0% since 2014.

Related: SBFM analyst forecast, SBFM key metrics. See the SBFM stock overview for the latest quote and news.

SBFM ownership FAQ

Who owns the most Sunshine Biopharma stock?

The largest shareholders of Sunshine Biopharma are Jane Street Group LLC (3.05%), Morgan Stanley - Brokerage Accounts (0.08%), SBI Securities Co Ltd (0.03%), NATIONAL BANK OF CANADA /FI/ (<0.01%), Advisor Group Holdings, Inc. (<0.01%).

What percentage of Sunshine Biopharma is owned by institutions?

Institutions hold 7.8% of Sunshine Biopharma's shares outstanding; insiders hold 6.43%.

Which funds own Sunshine Biopharma?

The largest fund holders of Sunshine Biopharma are Stewardship Partners US Multifactor (0.20%), Stewardship Partners Global Multifactor (0.08%), Stewardship Partners Glb Multi Tax-Eff (0.03%).

What is Sunshine Biopharma's short interest?

131K shares of Sunshine Biopharma were sold short, 3.10% of the float; at the average daily volume it would take 0.85 days to cover.

Are insiders buying or selling Sunshine Biopharma?

Of the latest 1 reported insider transactions in Sunshine Biopharma (since March 4, 2024), 1 were purchases and 0 were sales.

How many shares of Sunshine Biopharma are outstanding?

Sunshine Biopharma has 14.8M shares outstanding, of which 2.9M are in the public float.

Drug Manufacturers - Specialty & Generic: ownership